Los Angeles Capital Management
CDNA icon

Los Angeles Capital Management’s CareDx CDNA Stock Holding History

Los Angeles Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.17K Sell
240
-930
-79% -$17.6K ﹤0.01% 2177
2025
Q4 		$16.9K Buy
+1,170
New +$19.6K ﹤0.01% 1927
2025
Q2 		– Sell
-27,096
Closed -$481K – 1356
2025
Q1 		$481K Sell
27,096
-37,165
-58% -$800K ﹤0.01% 756
2024
Q4 		$1.38M Sell
64,261
-6,290
-9% -$153K 0.01% 537
2024
Q3 		$2.2M Sell
70,551
-41,385
-37% -$1.03M 0.01% 436
2024
Q2 		$1.74M Sell
111,936
-147,071
-57% -$1.78M 0.01% 483
2024
Q1 		$2.74M Buy
259,007
+21,892
+9% +$219K 0.01% 429
2023
Q4 		$2.85M Buy
237,115
+137,842
+139% +$1.13M 0.01% 411
2023
Q3 		$695K Buy
99,273
+262
+0.3% +$2.42K ﹤0.01% 752
2023
Q2 		$842K Sell
99,011
-9,209
-9% -$76.8K ﹤0.01% 693
2023
Q1 		$989K Buy
108,220
+5,988
+6% +$76.6K ﹤0.01% 674
2022
Q4 		$1.17M Buy
+102,232
New +$1.51M 0.01% 661
2022
Q1 		– Sell
-5,243
Closed -$238K – 1418
2021
Q4 		$238K Sell
5,243
-57
-1% -$2.98K ﹤0.01% 1310
2021
Q3 		$336K Hold
5,300
– – ﹤0.01% 1253
2021
Q2 		$485K Sell
5,300
-300
-5% -$23.8K ﹤0.01% 1179
2021
Q1 		$381K Sell
5,600
-340
-6% -$26.4K ﹤0.01% 1338
2020
Q4 		$430K Buy
+5,940
New +$344K ﹤0.01% 1264
2020
Q3 		– Sell
-28,633
Closed -$1.01M – 1442
2020
Q2 		$1.01M Sell
28,633
-17,907
-38% -$510K ﹤0.01% 840
2020
Q1 		$1.02M Buy
46,540
+19,795
+74% +$444K 0.01% 706
2019
Q4 		$577K Buy
+26,745
New +$614K ﹤0.01% 983

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Los Angeles Capital Management's CDNA Position: Q1 2026 in Review

Los Angeles Capital Management reduced its CareDx (CDNA) stake by 79% in Q1 2026, selling an estimated $17.6K and leaving 240 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

Los Angeles Capital Management first reported a position in CDNA in Q4 2019 and has held it in 20 quarters since. The position peaked at $2.85M in Q4 2023. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Los Angeles Capital Management held 240 shares of CareDx worth $4.17K as of Q1 2026.
  • Los Angeles Capital Management sold 930 CareDx shares in Q1 2026, an estimated $17.6K.
  • CareDx made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2177 holding.
  • Los Angeles Capital Management first reported a position in CareDx in Q4 2019 and has held it in 20 quarters since.
  • Los Angeles Capital Management's CareDx position peaked at $2.85M in Q4 2023.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.